chr2-201254251-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000264275.9(CASP8):​c.-26-12210G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 152,116 control chromosomes in the GnomAD database, including 3,507 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.16 ( 3507 hom., cov: 32)

Consequence

CASP8
ENST00000264275.9 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.192

Publications

7 publications found
Variant links:
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.377 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASP8NM_001228.5 linkc.-26-12210G>C intron_variant Intron 2 of 9 NP_001219.2
CASP8NM_001400648.1 linkc.-26-12210G>C intron_variant Intron 2 of 9 NP_001387577.1
CASP8NM_001400651.1 linkc.-26-12210G>C intron_variant Intron 2 of 9 NP_001387580.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASP8ENST00000264275.9 linkc.-26-12210G>C intron_variant Intron 2 of 9 1 ENSP00000264275.5
CASP8ENST00000392258.7 linkc.-26-12210G>C intron_variant Intron 2 of 7 1 ENSP00000376087.3
CASP8ENST00000471383.5 linkn.251-12210G>C intron_variant Intron 2 of 4 1

Frequencies

GnomAD3 genomes
AF:
0.160
AC:
24347
AN:
151998
Hom.:
3488
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.381
Gnomad AMI
AF:
0.0362
Gnomad AMR
AF:
0.0813
Gnomad ASJ
AF:
0.0939
Gnomad EAS
AF:
0.0119
Gnomad SAS
AF:
0.199
Gnomad FIN
AF:
0.0750
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.0717
Gnomad OTH
AF:
0.135
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.161
AC:
24418
AN:
152116
Hom.:
3507
Cov.:
32
AF XY:
0.160
AC XY:
11883
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.382
AC:
15807
AN:
41432
American (AMR)
AF:
0.0812
AC:
1242
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0939
AC:
326
AN:
3472
East Asian (EAS)
AF:
0.0120
AC:
62
AN:
5184
South Asian (SAS)
AF:
0.198
AC:
952
AN:
4818
European-Finnish (FIN)
AF:
0.0750
AC:
795
AN:
10606
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.0717
AC:
4874
AN:
67998
Other (OTH)
AF:
0.138
AC:
292
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
901
1803
2704
3606
4507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.134
Hom.:
309
Bravo
AF:
0.166
Asia WGS
AF:
0.156
AC:
542
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.50
DANN
Benign
0.41
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6736233; hg19: chr2-202118974; API